ADHD looks different in women and poses unique health risks
Recent coverage is re-evaluating ADHD clinical markers, identifying distinct symptom manifestations and hormonal interactions specific to women.
5 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 2 news categories, from Jun 26, 2026 through Jul 29, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
Recent coverage is re-evaluating ADHD clinical markers, identifying distinct symptom manifestations and hormonal interactions specific to women.
Patients aged six and older now have access to SIMTRIYO, the first new-class ADHD medication approved by the FDA in decades.
A new study suggests a link between addictive social media use in adolescent boys and the development or worsening of ADHD symptoms.
New research involving 120,000 siblings finds no link between prenatal Tylenol use and risks of autism or ADHD.
Adults and their children are increasingly exploring the complexities of neurodivergence, such as ADHD and autism, in older generations.